Press Releases
December 14, 2021
Panbela Announces Positive Preclinical Data Strongly Supporting the Activity of SBP-101 in Ovarian Cancer Cell Lines
Development Program for SBP-101’s Expansion into Ovarian Cancer Expected in 1H 2022
November 18, 2021
Panbela Announces Acceptance of Abstract for Poster Presentation at American Society of Clinical Oncology Gastrointestinal Cancers Symposium
November 10, 2021
Panbela Provides Business Update and Reports Q3 2021 Financial Results
October 25, 2021
Panbela Schedules Conference Call on Nov 10 to Report Q3 2021 Financial Results
September 7, 2021
Panbela to Present at Upcoming Investor Conferences
H.C. Wainwright 23rd Annual Global Investment Conference: September 13th to 15th, 2021
Oppenheimer Fall Healthcare Life Sciences & MedTech Summit: September 20-23
August 11, 2021
Panbela Provides Business Update and Reports Q2 2021 Financial Results
August 9, 2021
Panbela Announces Issuance of key U.S. Patent; Patent is for Claims of a Novel Process for the Production of SBP-101
Patent developed in collaboration with Syngene International Ltd
July 28, 2021
Panbela Schedules Conference Call on August 11 to Report 2021 Second Quarter Financial Results
July 7, 2021
Panbela to Present at Access to Giving Virtual Conference July 15 at 10:30 a.m. ET
July 2, 2021
Panbela Announces Closing of $10.0 Million Bought Deal Offering of Common Stock
Events & Presentations